{"title":"Comparison of Effectiveness of Transdiagnostic Treatment and Schema Therapy in Sleep Quality and Clinical Symptoms in Women with Migraine","authors":"Samaneh Sadat Jamshidi, Farzaneh Houman, Parviz Asgari","doi":"10.5812/jjcdc-136243","DOIUrl":null,"url":null,"abstract":"Background: Headache in migraine patients plays an important role in their quality of life. Objectives: This study aimed to compare the effectiveness of transdiagnostic treatment and schema therapy in sleep quality and clinical symptoms of migraine in women with migraines in 2022. Methods: This semi-experimental study was conducted with a pre-test, mid-test, post-test, and follow-up with a control group. The statistical population included all women aged 20 to 40 years diagnosed with migraine in Shahrekord, Iran, in 2022. A total of 45 individuals were selected as the sample from the women referring to specialized clinics in Shahrekord using the available sampling method and taking into account the inclusion criteria of the subjects. Moreover, the subjects were randomly assigned into two experimental groups and one control group (each group with 15 subjects). The research tools included the Ahvaz Migraine Questionnaire (Najarian, 1997), the Sleep Quality Scale (Buysse et al., 1989), the transdiagnostic treatment protocol (Barlow et al., 2017), and the schema therapy protocol (Young et al., 2003). To analyze the data, multivariate and univariate analysis of covariance was used using SPSS software (version 27). Results: The results showed that there was a significant difference in the overall mean scores of migraine clinical symptoms and sleep quality between the two groups of transdiagnostic treatment and schema therapy (P = 0.001). In general, it can be concluded that the transdiagnostic treatment method had a greater effect on the clinical syndrome scores of migraine and sleep quality than the schema therapy method (P = 0.001). Conclusions: The results supported the effect of transdiagnostic treatment and schema therapy, and paying attention to these two treatment methods is of particular importance for women with migraines. Therefore, the results of this study can become the basis for interventions to help migraine patients.","PeriodicalId":471457,"journal":{"name":"Jundishapur Journal of Chronic Disease Care","volume":"25 2","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jundishapur Journal of Chronic Disease Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/jjcdc-136243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Headache in migraine patients plays an important role in their quality of life. Objectives: This study aimed to compare the effectiveness of transdiagnostic treatment and schema therapy in sleep quality and clinical symptoms of migraine in women with migraines in 2022. Methods: This semi-experimental study was conducted with a pre-test, mid-test, post-test, and follow-up with a control group. The statistical population included all women aged 20 to 40 years diagnosed with migraine in Shahrekord, Iran, in 2022. A total of 45 individuals were selected as the sample from the women referring to specialized clinics in Shahrekord using the available sampling method and taking into account the inclusion criteria of the subjects. Moreover, the subjects were randomly assigned into two experimental groups and one control group (each group with 15 subjects). The research tools included the Ahvaz Migraine Questionnaire (Najarian, 1997), the Sleep Quality Scale (Buysse et al., 1989), the transdiagnostic treatment protocol (Barlow et al., 2017), and the schema therapy protocol (Young et al., 2003). To analyze the data, multivariate and univariate analysis of covariance was used using SPSS software (version 27). Results: The results showed that there was a significant difference in the overall mean scores of migraine clinical symptoms and sleep quality between the two groups of transdiagnostic treatment and schema therapy (P = 0.001). In general, it can be concluded that the transdiagnostic treatment method had a greater effect on the clinical syndrome scores of migraine and sleep quality than the schema therapy method (P = 0.001). Conclusions: The results supported the effect of transdiagnostic treatment and schema therapy, and paying attention to these two treatment methods is of particular importance for women with migraines. Therefore, the results of this study can become the basis for interventions to help migraine patients.
背景:偏头痛患者的头痛在其生活质量中起着重要作用。目的:本研究旨在比较2022年偏头痛女性患者的睡眠质量和临床症状的跨诊断治疗和图式治疗的有效性。方法:采用前测、中测、后测及对照组随访的半实验研究方法。统计人群包括2022年在伊朗Shahrekord被诊断患有偏头痛的所有20至40岁的女性。采用现有的抽样方法,并考虑到受试者的纳入标准,从Shahrekord专科诊所就诊的妇女中选出45人作为样本。将受试者随机分为2个实验组和1个对照组(每组15人)。研究工具包括Ahvaz偏头痛问卷(Najarian, 1997)、睡眠质量量表(Buysse et al., 1989)、跨诊断治疗方案(Barlow et al., 2017)和图式治疗方案(Young et al., 2003)。采用SPSS软件(27版)进行多因素和单因素协方差分析。结果:结果显示,两组患者在偏头痛临床症状和睡眠质量的总体平均评分上,跨诊断治疗组和图式治疗组有显著差异(P = 0.001)。总的来说,可以得出结论,跨诊断治疗方法对偏头痛临床综合征评分和睡眠质量的影响大于图式治疗方法(P = 0.001)。结论:结果支持跨诊断治疗和图式治疗的效果,对女性偏头痛患者特别重视这两种治疗方法。因此,本研究的结果可以成为帮助偏头痛患者的干预的基础。